Table 8 Sensitivity analysis including only patients aged >12 years with baseline parasitaemia of >500 per mcl
From: Do ethnobotanical and laboratory data predict clinical safety and efficacy of anti-malarial plants?
Remedy | RITAM score | Clinical results | Study characteristics | Refes | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | Ethnobotanical | Efficacy | Safety | Parasite clearance d7 (%) | Symptom clearance d7 (%) | Side effects (%) | ACR d14 (%) | N of patients | Baseline parasitaemia (gm) | ||
Artemisia annua aerial parts infusion | 19.9 | 0.9 | 13 | 6 | 74% | 86% | 72 | [27] | |||
Vernonia amygdalina leaf decoction | 17.0 | 5.0 | 6 | 6 | 32% | 67% | 65% | 67% | 33 | 5393 | [28] |
Argemone mexicana leaf decoction | 14.9 | 1.9 | 7 | 6 | 50% | 88% | 13% | 94% | 16 | 3162 | [30]* |
Cochlospermum planchonii root decoction | 6.0 | 1.0 | 2 | 3 | 52% | 62% | 46% | 46 | 11191 | [29] | |